This report contains market size and forecasts of Pregabalin API in global, including the following market information:
Global Pregabalin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pregabalin API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Pregabalin API companies in 2021 (%)
The global Pregabalin API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pregabalin API include SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pregabalin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pregabalin API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pregabalin API Market Segment Percentages, by Type, 2021 (%)
Purity ≥99%
Purity ≥99.5%
Global Pregabalin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pregabalin API Market Segment Percentages, by Application, 2021 (%)
Tablet
Capsule
Oral Liquid
Global Pregabalin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Pregabalin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pregabalin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pregabalin API revenues share in global market, 2021 (%)
Key companies Pregabalin API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Pregabalin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SUANFARMA
VASUDHA PHARMA
Atom Pharma
Sienna Biotec
Kopran
Teva
Afton Pharma
Cadila
Sunshine Pharmaceutical
Hanmi Fine Chemical
Rivocean Jiangsu Pharmaceutical
Hubei Vanz Pharm
Menovo
Saintsun
SyncoZymes
Taian Aidi Biotechnology